361 results on '"Bristow, M. R."'
Search Results
2. β-Adrenergic Receptor Dysfunction in the Pathogenesis of Idiopathic Dilated Cardiomyopathy
3. The β-Adrenergic Receptor-G Protein-Adenylate Cyclase Complex in Idiopathic Dilated Cardiomyopathy
4. Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes
5. Carvedilol treatment of chronic heart failure: a new era
6. Cyclophosphamide in cardiac transplant recipients with frequent rejection: a six-year retrospective review
7. Metropolitan Planning Revisited The London Case
8. A Woman in Planning, or Metropolitan Planning Revisited — 1984
9. To Plan or Not to Plan, That is the Question — Again
10. How Unitary is Unitary? Some Comments on the New British Unitary Plan System
11. Some Problems of Methodology Transfer: Strategic Planning in Malaysia and Hong Kong
12. Cardiac Monitoring of Patients Receiving Anthracyclines
13. Rationale and Design of a Trial to Evaluate the Cardiotoxocity of Weekly Schedules of Adriamycin, with Endomyocardial Biopsy used as an End Point
14. Heterogeneous regulatory changes in cell surface membrane receptors coupled to a positive inotropic response in the failing human heart
15. Antagonism of the sympathetic nervous system in heart failure
16. Myocardial-directed overexpression of the human b1-adrenergic receptor in transgenic mice
17. Preliminary characterization of a transgenic mouse overexpressing the human b1-adrenergic receptor
18. Regulation of the mRNA-binding protein AUF1 by activation of the b-adrenergic receptor signal transduction pathway
19. Regulation of p37AUF1, an mRNA binding protein, in human ventricular myocardium
20. 103 THE PEROXISOMAL PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA REGULATORY PATHWAY IS ACTIVATED IN PATIENTS WITH SEVERE IDIOPATHIC DILATED CARDIOMYOPATHY
21. Congestive Heart Failure: Fifty Years of Progress
22. Inotropes in the beta-blocker era
23. FK506 IS A SAFE AND EFFECTIVE TREATMENT FOR MODERATE REJECTION IN HEART TRANSPLANT RECIPIENTS
24. Myosin heavy chain gene expression in human heart failure.
25. Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.
26. Beta-blocking agents in heart failure Should they be used and how?
27. Cardiac adrenergic receptor effects of carvedilol
28. Anti-adrenergic effects of angiotensin converting enzyme inhibitors
29. Improvement in cardiac myocyte function by biological effects of medical therapy: A new concept in the treatment of heart failure
30. Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators.
31. Reduced beta 1 receptor messenger RNA abundance in the failing human heart.
32. Lisinopril lowers cardiac adrenergic drive and increases beta-receptor density in the failing human heart.
33. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms.
34. Myocardial catecholamine and neuropeptide Y depletion in failing ventricles of patients with idiopathic dilated cardiomyopathy. Correlation with beta-adrenergic receptor downregulation.
35. Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy.
36. Sarcoplasmic reticulum-associated cyclic adenosine 5'-monophosphate phosphodiesterase activity in normal and failing human hearts.
37. Selective gene expression in failing human heart. Quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction.
38. A1-adenosine receptor inhibition of adenylate cyclase in failing and nonfailing human ventricular myocardium.
39. The surgically denervated, transplanted human heart.
40. Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart.
41. Signaling pathways responsible for fetal gene induction in the failing human heart: evidence for altered thyroid hormone receptor gene expression.
42. Regional Planning: A Review Article.
43. Cardiac transplantation: emerging role of the internist/cardiologist.
44. Efficacy of diltiazem for medically refractory stable angina: Long-Term follow-up.
45. The β-adrenergic receptor-adenylate cyclase complex as a target for therapeutic intervention in heart failure.
46. β-adrenoceptor regulation in the human heart: can it be monitored in circulating lymphocytes?
47. Myocardial α- and β-adrenergic receptors in heart failure: is cardiac-derived norepinephrine the regulatory signal?
48. The Relationship of Plasma Ionized Calcium to Cardiovascular Disease Endpoint and Family History of Hypertension.
49. Efficacy and cost of cardiac monitoring in patients receiving doxorubicin.
50. Town Planning Responses to City Change V. Nadin J. Doak
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.